{"id":"tropicamide-ophthalmic","safety":{"commonSideEffects":[{"rate":"10-20%","effect":"Dry mouth"},{"rate":"5-10%","effect":"Blurred vision"},{"rate":"5-10%","effect":"Headache"}]},"_chembl":{"chemblId":"CHEMBL1200604","moleculeType":"Small molecule","molecularWeight":"284.36"},"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"By blocking muscarinic receptors, tropicamide Ophthalmic reduces the parasympathetic tone on the iris sphincter muscle, leading to pupil dilation and paralysis of accommodation. This effect is reversible and typically lasts for several hours.","oneSentence":"Tropicamide Ophthalmic is an anticholinergic agent that works by blocking muscarinic receptors in the eye to induce mydriasis and cycloplegia.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T01:40:12.005Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Induction of mydriasis and cycloplegia for ophthalmic examinations"}]},"trialDetails":[{"nctId":"NCT07495670","phase":"NA","title":"Comparison of 4 Methods of Eye Drops for Pupil Dilation in Diabetic Patients","status":"COMPLETED","sponsor":"Burapha University","startDate":"2024-11-04","conditions":"Diabetes (DM), Retinopathy, Diabetic, Pupil Dilation","enrollment":84},{"nctId":"NCT07419776","phase":"","title":"The Effect Of Polycystic Ovarian Syndrome Treatment On Ocular Surface.","status":"COMPLETED","sponsor":"Cairo University","startDate":"2023-06-24","conditions":"Poly Cystic Ovary Syndrome","enrollment":90},{"nctId":"NCT00227253","phase":"","title":"Chromosome 18 Clinical Research Center","status":"RECRUITING","sponsor":"The University of Texas Health Science Center at San Antonio","startDate":"1993-09","conditions":"Chromosome Aberrations, Growth Hormone Deficiency, Hypomyelination","enrollment":4000},{"nctId":"NCT04712747","phase":"","title":"Adaptive Optics (AO) Analysis of Retinal Arteries in Patients With Recent Stroke (STROKAO)","status":"COMPLETED","sponsor":"Fondation Ophtalmologique Adolphe de Rothschild","startDate":"2021-01-25","conditions":"Stroke","enrollment":91},{"nctId":"NCT07178600","phase":"","title":"Clinical Determinants and Adverse Reactions to Tropicamide/Phenylephrine in Hospitalized Patients.","status":"RECRUITING","sponsor":"Instituto de Oftalmología Fundación Conde de Valenciana","startDate":"2023-09-02","conditions":"Adverse Drug Effect, Phenylephrine, Hypertension","enrollment":1000},{"nctId":"NCT07088705","phase":"NA","title":"Subthreshold Micropulse Laser Therapy (SML) in Retinitis Pigmentosa","status":"ENROLLING_BY_INVITATION","sponsor":"Marta P. Wiącek","startDate":"2024-09-01","conditions":"Retinitis Pigmentosa (RP)","enrollment":60},{"nctId":"NCT07075224","phase":"PHASE1, PHASE2","title":"Pharmacodynamics of a Fixed Dose Combination of 0.34% Tropicamide and 2.5% Phenylephrine Hydrochloride, Eye Drop, Solution","status":"NOT_YET_RECRUITING","sponsor":"Unither Pharmaceuticals, France","startDate":"2025-07-15","conditions":"Mydriasis","enrollment":20},{"nctId":"NCT05747547","phase":"","title":"Retinal Vascular Changes in Patients After Coronavirus Disease 2019 (COVID-19)","status":"COMPLETED","sponsor":"University Hospital Olomouc","startDate":"2022-08-01","conditions":"COVID-19","enrollment":34},{"nctId":"NCT06161636","phase":"","title":"Contribution of the Kinematic Theory in the Early Differential Diagnosis of the Parkinson's Disease","status":"RECRUITING","sponsor":"Centre hospitalier de l'Université de Montréal (CHUM)","startDate":"2020-02-19","conditions":"Parkinson Disease, Healthy, Parkinsonian Syndromes","enrollment":90},{"nctId":"NCT04907474","phase":"PHASE4","title":"Evaluation of Pupil Dilation Speed With the MAP Dispenser","status":"COMPLETED","sponsor":"Eyenovia Inc.","startDate":"2021-05-24","conditions":"Mydriasis","enrollment":61},{"nctId":"NCT06649513","phase":"","title":"Long-term Ophthalmic Outcomes in Ex-premature Infants","status":"NOT_YET_RECRUITING","sponsor":"Erasmus Medical Center","startDate":"2024-11-01","conditions":"Retinopathy of Prematurity (ROP), Premature Birth","enrollment":210},{"nctId":"NCT06366217","phase":"PHASE4","title":"Efficacy of the MydCombi on Pupillary Dilation in Pediatric and Adult Patients","status":"NOT_YET_RECRUITING","sponsor":"University of California, San Francisco","startDate":"2024-09-30","conditions":"Dilation, Pupil Reaction Absent","enrollment":100},{"nctId":"NCT02023086","phase":"","title":"Clinical Investigation on the Blood Oxygenation at the Optic Nerve Head in Fabry Patients","status":"COMPLETED","sponsor":"Université de Montréal","startDate":"2014-08","conditions":"Fabry Disease","enrollment":8},{"nctId":"NCT06213896","phase":"","title":"Detecting Eye Diseases Via Hybrid Deep Learning Algorithms From Fundus Images","status":"COMPLETED","sponsor":"Ural Telekomunikasyon Sanayi Ticaret Anonim Sirketi","startDate":"2023-03-01","conditions":"Glaucoma, Age-Related Macular Degeneration, Retinal Vein Occlusion","enrollment":1528},{"nctId":"NCT06217796","phase":"PHASE4","title":"Safety and Efficacy of Fixed Combination Phenylephrine-Tropicamide for Pupil Dilation","status":"COMPLETED","sponsor":"Eyenovia Inc.","startDate":"2023-11-28","conditions":"Mydriasis","enrollment":30},{"nctId":"NCT06306690","phase":"","title":"Biomarkers in Retinitis Pigmentosa","status":"RECRUITING","sponsor":"Fondazione Policlinico Universitario Agostino Gemelli IRCCS","startDate":"2024-02-01","conditions":"Retinitis Pigmentosa","enrollment":35},{"nctId":"NCT03959176","phase":"PHASE4","title":"The Effect of Brimonidine","status":"COMPLETED","sponsor":"Wake Forest University Health Sciences","startDate":"2019-07-20","conditions":"Intraocular Pressure","enrollment":13},{"nctId":"NCT06120894","phase":"","title":"Strip Meniscometry in Dry Eye Evaluation","status":"COMPLETED","sponsor":"University Hospital Olomouc","startDate":"2021-11-01","conditions":"Dry Eye, Dry Eye Disease","enrollment":21},{"nctId":"NCT06077682","phase":"PHASE4","title":"Cycloplegic Refraction in Pediatric Patients With Esotropia","status":"UNKNOWN","sponsor":"Islamic Hospital, Jordan","startDate":"2023-09-01","conditions":"Cycloplegia, Refractive Errors, Esotropia","enrollment":100},{"nctId":"NCT05223478","phase":"PHASE3","title":"Nyxol (0.75% Phentolamine Ophthalmic Solution) to Reverse Pharmacologically-Induced Mydriasis in Pediatric Subjects","status":"COMPLETED","sponsor":"Ocuphire Pharma, Inc.","startDate":"2021-12-17","conditions":"Mydriasis, Dilation","enrollment":23},{"nctId":"NCT05925894","phase":"NA","title":"Efficacy Mydrane ® for Cataract Surgery in Patients With Concomitant Primary Open Angle Glaucoma.","status":"COMPLETED","sponsor":"Fondazione Policlinico Universitario Agostino Gemelli IRCCS","startDate":"2021-03-18","conditions":"Cataract Surgery","enrollment":60},{"nctId":"NCT05880433","phase":"","title":"The Effects of Mydriatic Eye Drops in Retinopathy of Prematurity Examinations","status":"COMPLETED","sponsor":"Istanbul Training and Research Hospital","startDate":"2021-05-01","conditions":"Retinopathy of Prematurity, Mydriasis, Neonatal Disease","enrollment":62},{"nctId":"NCT05771194","phase":"PHASE4","title":"Analysis of Postoperative Ocular Surface Changes and Intervention Effect After PPV in MGD Dry Eye Patients","status":"COMPLETED","sponsor":"Tianjin Medical University Eye Hospital","startDate":"2021-02-01","conditions":"Meibomian Gland Dysfunction of Unspecified Eye, Unspecified Eyelid","enrollment":40},{"nctId":"NCT05238233","phase":"PHASE4","title":"Wearing-Off Period of Pharmacological Dilation and Anisocoria","status":"COMPLETED","sponsor":"Prisma Health-Upstate","startDate":"2022-04-01","conditions":"Anisocoria","enrollment":11},{"nctId":"NCT05449015","phase":"PHASE4","title":"Study on the Effect of Two Ways of Cycloplegia on Biological Parameters of Ciliary Muscle","status":"UNKNOWN","sponsor":"Shanghai Eye Disease Prevention and Treatment Center","startDate":"2020-12-22","conditions":"Accomodation, Refractive Errors, Myopia","enrollment":144},{"nctId":"NCT05566626","phase":"NA","title":"Retinal Oxygenation Estimation Trial With Mantis Photonics Hyperspectral Camera","status":"UNKNOWN","sponsor":"Mantis Photonics AB","startDate":"2022-10","conditions":"Glaucoma Eye, Macular Degeneration, Macula Abnormality","enrollment":120},{"nctId":"NCT03201562","phase":"PHASE2","title":"A Single-Center, Double-Masked Evaluation of the Efficacy and Safety of PRX-100 in the Treatment of Early to Moderate Presbyopia","status":"COMPLETED","sponsor":"LENZ Therapeutics, Inc","startDate":"2017-04-30","conditions":"Presbyopia","enrollment":58},{"nctId":"NCT05442801","phase":"PHASE4","title":"Cycloplegic Refraction Among Children","status":"COMPLETED","sponsor":"Islamic Hospital, Jordan","startDate":"2022-03-01","conditions":"Cycloplegia","enrollment":55},{"nctId":"NCT04040790","phase":"NA","title":"Performance of Rigid Gas Permeable (RGP) Scleral Contact Lenses With a Passive Artificial Iris","status":"TERMINATED","sponsor":"University Ghent","startDate":"2019-09-16","conditions":"Low Vision","enrollment":10},{"nctId":"NCT03751631","phase":"PHASE3","title":"Safety and Efficacy of Phenylephrine 2.5%-Tropicamide 1% Microdose Ophthalmic Solution for Pupil Dilation","status":"COMPLETED","sponsor":"Eyenovia Inc.","startDate":"2018-11-15","conditions":"Mydriasis","enrollment":70},{"nctId":"NCT03751098","phase":"PHASE3","title":"Safety and Efficacy of Phenylephrine 2.5%-Tropicamide 1% Microdose Ophthalmic Solution for Pupil Dilation","status":"COMPLETED","sponsor":"Eyenovia Inc.","startDate":"2018-12-01","conditions":"Mydriasis","enrollment":76},{"nctId":"NCT04932213","phase":"PHASE3","title":"Effect of Tropicamide 0.5% vs Tropicamide 1% on Intraocular Pressure of Diabetic Patients","status":"COMPLETED","sponsor":"Semnan University of Medical Sciences","startDate":"2021-07-07","conditions":"Type 2 Diabetes Mellitus, Type 1 Diabetes Mellitus","enrollment":98},{"nctId":"NCT04880928","phase":"PHASE4","title":"Comparison Mydriasis by Mydrane With Topical Drop Application","status":"COMPLETED","sponsor":"Medical University of Graz","startDate":"2020-08-12","conditions":"Cataract","enrollment":42},{"nctId":"NCT04468022","phase":"NA","title":"Toric Trifocal IOL Treatment With High Astigmatism and Hyperopia vs SMILE Enhancement After Trifocal IOL Treatment","status":"COMPLETED","sponsor":"Eye Hospital Pristina Kosovo","startDate":"2018-06-01","conditions":"Astigmatism High Both, Pseudophakia, Hyperopia","enrollment":40},{"nctId":"NCT00748059","phase":"PHASE1","title":"The Pathophysiology of Orthostatic Hypotension","status":"COMPLETED","sponsor":"Vanderbilt University Medical Center","startDate":"1996-12","conditions":"Autonomic Nervous System Diseases, Orthostatic Hypotension, Dopamine Beta-Hydroxylase Deficiency","enrollment":10},{"nctId":"NCT02373137","phase":"PHASE4","title":"Descemet Endothelial Thickness Comparison Trial","status":"UNKNOWN","sponsor":"Oregon Health and Science University","startDate":"2015-01-22","conditions":"Keratoplasty, Grafting, Corneal, Transplantation, Corneal","enrollment":38},{"nctId":"NCT04396301","phase":"PHASE3","title":"Effect of Intracameral Injection of Mydriatic Plus Anaesthetic Combination on Corneal Endothelial Count in Phaco","status":"COMPLETED","sponsor":"Cairo University","startDate":"2019-02-01","conditions":"Corneal Endothelial Cell Loss, Mydriasis, Cataract","enrollment":30},{"nctId":"NCT04117698","phase":"PHASE3","title":"Multicenter, Randomized Study Evaluating the Value of Antitubercular Treatment During Recurent Anterior Uveitis (URBA)","status":"UNKNOWN","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2019-11-01","conditions":"Uveitis, Anterior","enrollment":116},{"nctId":"NCT03139708","phase":"PHASE1","title":"The Effect of Brimonidine on Intraocular Pressure When Dilating Routine Patients","status":"COMPLETED","sponsor":"Wake Forest University Health Sciences","startDate":"2016-09","conditions":"Intraocular Pressure","enrollment":5},{"nctId":"NCT01982383","phase":"NA","title":"Study on the Use of Micropulse Laser to Treat Central Serous Chorioretinopathy","status":"TERMINATED","sponsor":"George Washington University","startDate":"2012-11","conditions":"Central Serous Chorioretinopathy","enrollment":2},{"nctId":"NCT03448640","phase":"","title":"Efficacy of Mydriatic Drops in Premature Infants","status":"COMPLETED","sponsor":"Bulent Ecevit University","startDate":"2016-01-15","conditions":"Retinopathy of Prematurity","enrollment":60},{"nctId":"NCT02554396","phase":"PHASE2","title":"Evaluation of the Efficacy and Safety of PRX-100 in the Treatment of Early to Moderate Presbyopia","status":"COMPLETED","sponsor":"LENZ Therapeutics, Inc","startDate":"2015-09","conditions":"Presbyopia","enrollment":20},{"nctId":"NCT03097198","phase":"NA","title":"Effect of Plum-blossom Needle vs. Tropicamide Eye Drops on Juvenile Myopia","status":"UNKNOWN","sponsor":"Wenzhou Medical University","startDate":"2016-12","conditions":"Myopia","enrollment":98},{"nctId":"NCT02280135","phase":"PHASE1","title":"Clinical Trial of Intravitreal Injection of Autologous Bone Marrow Stem Cells in Patients With Retinitis Pigmentosa","status":"COMPLETED","sponsor":"Red de Terapia Celular","startDate":"2014-11","conditions":"Retinitis Pigmentosa","enrollment":8},{"nctId":"NCT02304861","phase":"NA","title":"Viscoat Versus Visthesia. A Comparative Study of Post-cataract Endothelial Cell Loss","status":"COMPLETED","sponsor":"Democritus University of Thrace","startDate":"2014-01","conditions":"Cataract","enrollment":80},{"nctId":"NCT02895074","phase":"NA","title":"Subfoveal Choroidal Thickness After Surgery for Age-related Cataracts","status":"COMPLETED","sponsor":"Sun Yat-sen University","startDate":"2014-08","conditions":"Cataract","enrollment":40},{"nctId":"NCT02443129","phase":"NA","title":"Swept Source Enhanced Depth Imaging Optical Coherence Tomography","status":"UNKNOWN","sponsor":"Shaare Zedek Medical Center","startDate":"2016-05","conditions":"Retina, Choroid, Sclera","enrollment":120},{"nctId":"NCT02101359","phase":"PHASE3","title":"Efficacy and Safety Assessment of Intracameral Injection of T2380 in Cataract Surgery","status":"COMPLETED","sponsor":"Laboratoires Thea","startDate":"2011-06","conditions":"Cataract","enrollment":609},{"nctId":"NCT01809483","phase":"PHASE3","title":"Comparison Between Bandage Contact Lens and Pressure Patching for The Erosion Area and Pain Scale in Corneal Erosion Patients","status":"COMPLETED","sponsor":"Udayana University","startDate":"2012-09","conditions":"Erosion; Cornea, Traumatic","enrollment":32},{"nctId":"NCT00877175","phase":"PHASE4","title":"Comparison of Instillation and Packing in Mydriasis for Premature Infants","status":"COMPLETED","sponsor":"Khon Kaen University","startDate":"2009-03","conditions":"Preterm Infants","enrollment":25},{"nctId":"NCT01075347","phase":"PHASE1","title":"Topical Autologous Serum Application for the Treatment of Corneal Epithelium Defect After Ocular Surgeries","status":"COMPLETED","sponsor":"National Taiwan University Hospital","startDate":"2007-03","conditions":"Corneal Epithelial Defect, Diabetic Retinopathy, Penetrating Keratoplasty","enrollment":165},{"nctId":"NCT00642135","phase":"PHASE3","title":"CLAIR -FO: Clinical Trial of Ophthalmic Insert Mydriasert® Versus Reference Treatment","status":"TERMINATED","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2006-01","conditions":"Retinal Anomalies, Premature Birth","enrollment":80}],"_emaApprovals":[],"_faersSignals":[{"count":10,"reaction":"DRUG EFFECT PROLONGED"},{"count":9,"reaction":"MYDRIASIS"},{"count":7,"reaction":"VISION BLURRED"},{"count":5,"reaction":"DRUG INEFFECTIVE"},{"count":5,"reaction":"EYE IRRITATION"},{"count":5,"reaction":"PRODUCT QUALITY ISSUE"},{"count":4,"reaction":"EYE PAIN"},{"count":3,"reaction":"CONDITION AGGRAVATED"},{"count":3,"reaction":"HEADACHE"},{"count":3,"reaction":"PUPIL FIXED"}],"_approvalHistory":[],"publicationCount":11,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Mydrax (Sina Darou)"],"phase":"phase_3","status":"active","brandName":"Tropicamide Ophthalmic","genericName":"Tropicamide Ophthalmic","companyName":"Semnan University of Medical Sciences","companyId":"semnan-university-of-medical-sciences","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Tropicamide Ophthalmic is a small molecule that acts as a muscarinic acetylcholine receptor M3 antagonist. It is used to treat conditions such as intraocular pressure and cycloplegia, and is also used in diagnostic procedures such as optical coherence tomography angiography.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":1,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}